The Business Research Company’s Minimally Invasive Glaucoma Surgery Devices Market: Trends, Segments & Regional Growth
LONDON, GREATER LONDON, UNITED KINGDOM, August 18, 2026 /EINPresswire.com/ — “The minimally invasive glaucoma surgery (MIGS) devices sector is experiencing rapid advancement as new technologies and growing awareness about eye health reshape treatment options. This market is attracting significant attention due to its promise of safer, more efficient glaucoma management with quicker recovery times. Let’s explore the current market size, driving factors, regional insights, and emerging trends that are shaping the future of MIGS devices.
Steady Growth and Market Size of the Minimally Invasive Glaucoma Surgery Devices Market
The minimally invasive glaucoma surgery devices market has witnessed remarkable expansion in recent years. Projections indicate that the market will rise from $0.89 billion in 2025 to $1.14 billion in 2026, reflecting an impressive compound annual growth rate (CAGR) of 28.1%. This upward trend during the historic period has been fueled by factors such as the increasing incidence of glaucoma, an aging global population, limitations associated with traditional glaucoma surgeries, growing awareness of the benefits of preserving vision, and the rising number of cataract surgeries being performed.
Download a free sample of the minimally invasive glaucoma surgery (migs) devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
Future Market Potential and Growth Forecast for MIGS Devices
Looking ahead, the minimally invasive glaucoma surgery devices market is set to experience even greater growth. By 2030, the market size is expected to soar to $2.79 billion, with a CAGR of 24.9% during the forecast period. This surge is driven by the expanding pool of glaucoma patients, wider acceptance of minimally invasive surgical options, increased demand for outpatient ophthalmic procedures, a stronger focus on enhancing quality-of-life outcomes, and improved access to specialized eye care clinics. Key trends shaping this growth include the broader adoption of MIGS in treating early and moderate-stage glaucoma, frequent use of MIGS alongside cataract surgeries, growth in outpatient and ambulatory glaucoma operations, as well as a rising preference for glaucoma treatments that offer faster recovery and better safety profiles.
Understanding Minimally Invasive Glaucoma Surgery Devices and Their Benefits
MIGS devices are specialized medical tools designed to reduce intraocular pressure (IOP) by employing less invasive surgical approaches compared to conventional glaucoma procedures. The primary goal of these devices is to lower the risk of complications, shorten patient recovery times, and improve overall treatment outcomes. By offering a safer and gentler alternative, MIGS devices provide a critical option for patients needing surgical intervention to control glaucoma progression while minimizing disruption to their daily lives.
View the full minimally invasive glaucoma surgery (migs) devices market report:
https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
The Rising Impact of Eye Disorders on the MIGS Devices Market
One of the main factors propelling the minimally invasive glaucoma surgery devices market is the growing prevalence of eye disorders globally. These conditions, which affect vision and eye health, are becoming more common due to lifestyle changes, environmental factors, and aging populations worldwide. MIGS devices play an essential role in managing such diseases, especially by targeting intraocular pressure to prevent or slow down glaucoma. For example, the National Eye Institute, a US government agency, reported that by 2030 approximately 2.2 million Americans will be either blind or partially blind. This stark statistic highlights the urgent need for effective glaucoma management solutions, which directly supports the expansion of the MIGS devices market.
North America’s Leading Position and Asia-Pacific’s Rapid Growth in MIGS Devices
In 2025, North America held the largest share of the minimally invasive glaucoma surgery devices market. However, Asia-Pacific is poised to become the fastest-growing region over the forecast period. The comprehensive market report covers multiple key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a global perspective on market dynamics and regional opportunities.
New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
